hand and heart

The recent post office troubles have impacted our regular fundraising efforts. Please consider supporting the Register and Catholic journalism by using one of the methods below:

  • Donate online
  • Donate by e-transfer to accounting@catholicregister.org
  • Donate by telephone: 416-934-3410 ext. 406 or toll-free 1-855-441-4077 ext. 406
Charlie Gard, who was born in England with mitochondrial DNA depletion syndrome, is pictured in this undated family photo. CNS photo/family handout, courtesy Featureworld

London hospital seeks another hearing in Charlie Gard case

By 
  • July 10, 2017

LONDON, England – Great Ormond Street Hospital in London is applying for a new hearing with the high court after new evidence suggests the critically ill baby could benefit from an experimental treatment.

The decision comes after a team of seven international medical experts alerted the hospital that fresh, unpublished data suggested that an experimental drug could improve Charlie’s brain condition.

One of the signatories of the letter is a researcher and neurologist with the Vatican-owned Bambino Gesu Hospital in Rome, which offered to transfer Charlie to their facilities earlier this week. Great Ormond Hospital said they denied the transfer for legal reasons.

"Two international hospitals and their researchers have communicated to us as late as the last 24 hours that they have fresh evidence about their proposed experimental treatment,” a hospital spokesman said, according to the BBC.

"We believe, in common with Charlie's parents, it is right to explore this evidence,” they said.

"Great Ormond Street Hospital is giving the High Court the opportunity to objectively assess the claims of fresh evidence...It will be for the High Court to make its judgment on the facts,” they said.

Charlie has been diagnosed with mitochondrial depletion syndrome, a rare genetic disease thought to affect just 16 children in the world. The disease causes progressive muscle weakness and can cause death in the first year of life.

Charlie’s case has caught international attention for the various legal battles that his parents, Chris Gard and Connie Yates, have fought in an attempt to save their son’s life.

The current decision of the hospital to apply for the appeal comes as a surprise after Charlie’s parents were denied their request by the High Court to take Charlie to a hospital in the United States to seek experimental treatment, even after they had raised over $1 million to take him there. Charlie’s parents were also denied their request to take their son home to die.

Both the Vatican paediatric hospital and Pope Francis have expressed their support for Charlie.

“The Holy Father follows with affection and emotion the story of Charlie Gard and expresses his own closeness to his parents,” read a July 2 statement issued by Vatican spokesman Greg Burke.

“He prays for them, wishing that their desire to accompany and care for their own child to the end will be respected.”

On June, the day the Charlie’s life support was initially scheduled to be disconnected, the Pope also used his Twitter account to send a clear pro-life message in the infant's favour:

“To defend human life, above all when it is wounded by illness, is a duty of love that God entrusts to all.”

Charlie's case will be heard by Justice Francis on Monday at 2 p.m. local time (9 a.m. Eastern) according to a High Court listing.

(Catholic News Agency)

Please support The Catholic Register

Unlike many media companies, The Catholic Register has never charged readers for access to the news and information on our website. We want to keep our award-winning journalism as widely available as possible. But we need your help.

For more than 125 years, The Register has been a trusted source of faith-based journalism. By making even a small donation you help ensure our future as an important voice in the Catholic Church. If you support the mission of Catholic journalism, please donate today. Thank you.

DONATE